(Q40573363)

English

Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation

scientific article published on October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation (English)

1 reference

Europe PubMed Central

21 September 2017

1 reference

based on heuristic

inferred from title

author name string

Egerer G

1

1 reference

Europe PubMed Central

21 September 2017

Goldschmidt H

2

1 reference

Europe PubMed Central

21 September 2017

Hensel M

3

1 reference

Europe PubMed Central

21 September 2017

Harter C

4

1 reference

Europe PubMed Central

21 September 2017

Schneeweiss A

5

1 reference

Europe PubMed Central

21 September 2017

Ehrhard I

6

1 reference

Europe PubMed Central

21 September 2017

Bastert G

7

1 reference

Europe PubMed Central

21 September 2017

Ho AD

8

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

21 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

21 September 2017

30

1 reference

Europe PubMed Central

21 September 2017

7

1 reference

Europe PubMed Central

21 September 2017

427-431

1 reference

Europe PubMed Central

21 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703660

0 references

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Infection in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

A randomized clinical trial of ceftriaxone and teicoplanin versus ceftazidime and teicoplanin as antibiotic therapy in febrile neutropenic cancer patients and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Ceftriaxone alone or in Combination with Teicoplanin in the Management of Febrile Episodes in Neutropenic Children and Adolescents with Cancer on an Outpatient Base

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Self-administered antibiotic therapy for chemotherapy-induced, low-risk febrile neutropenia in patients with nonhematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

21 January 2018

Is it time to redefine the management of febrile neutropenia in cancer patients?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

7 January 2021

based on heuristic

inferred from DOI database lookup

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral versus Intravenous Empirical Antimicrobial Therapy for Fever in Patients with Granulocytopenia Who Are Receiving Cancer Chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703660

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703660

1 reference

Europe PubMed Central

21 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40573363&oldid=2050616949"